Page 4 - Codexis Daily News Today

Codexis (NASDAQ:CDXS – Get Free Report) and LanzaTech Global (NASDAQ:LNZA – Get Free Report) are both small-cap medical companies, but which is the better investment? We will compare the two businesses based on the strength of their risk, earnings, analyst recommendations, institutional ownership, profitability, valuation and dividends. Insider & Institutional Ownership 88.0% of Codexis shares […]

Codexis (NASDAQ:CDXS – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.04, Briefing.com reports. Codexis had a negative net margin of 41.17% and a negative return on equity of 32.75%. The company had revenue of […]

Codexis (NASDAQ:CDXS – Get Free Report) issued its quarterly earnings results on Thursday. The biotechnology company reported ($0.17) earnings per share for the quarter, topping analysts’ consensus estimates of ($0.21) by $0.04, Briefing.com reports. Codexis had a negative net margin of 41.17% and a negative return on equity of 32.75%. The company had revenue of […]

Codexis (NASDAQ:CDXS – Get Free Report) released its earnings results on Thursday. The biotechnology company reported ($0.17) EPS for the quarter, beating the consensus estimate of ($0.21) by $0.04, Briefing.com reports. The firm had revenue of $21.32 million for the quarter, compared to analysts’ expectations of $19.83 million. Codexis had a negative net margin of […]

StockNews.com lowered shares of Codexis (NASDAQ:CDXS – Free Report) from a hold rating to a sell rating in a research report sent to investors on Friday morning. A number of other research analysts have also recently commented on the stock. Stephens reissued an overweight rating and issued a $6.00 target price on shares of Codexis […]

Codexis, Inc. (NASDAQ:CDXS – Free Report) was the target of a large decrease in short interest during the month of June. As of June 15th, there was short interest totalling 3,140,000 shares, a decrease of 19.9% from the May 31st total of 3,920,000 shares. Based on an average trading volume of 908,100 shares, the days-to-cover […]

Codexis (NASDAQ:CDXS – Get Rating) and Verde Clean Fuels (NASDAQ:VGAS – Get Rating) are both small-cap medical companies, but which is the superior business? We will compare the two businesses based on the strength of their profitability, valuation, risk, institutional ownership, earnings, analyst recommendations and dividends. Analyst Recommendations This is a breakdown of recent ratings […]

Opaleye Management Inc. lowered its position in Codexis, Inc. (NASDAQ:CDXS – Get Rating) by 17.1% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 957,500 shares of the biotechnology company’s stock after selling 197,500 shares during the quarter. Codexis makes up […]

StockNews.com upgraded shares of Codexis (NASDAQ:CDXS – Get Rating) from a sell rating to a hold rating in a research note issued to investors on Tuesday. Other equities research analysts also recently issued research reports about the company. HC Wainwright downgraded Codexis from a buy rating to a neutral rating in a report on Tuesday, […]

StockNews.com downgraded shares of Codexis (NASDAQ:CDXS – Get Rating) from a hold rating to a sell rating in a research report report published on Monday morning. CDXS has been the topic of a number of other reports. Piper Sandler lowered their price target on Codexis from $21.00 to $14.00 and set an overweight rating on […]